Literature DB >> 9417864

Elevated levels of mortalin expression in human brain tumors.

S Takano1, R Wadhwa, Y Yoshii, T Nose, S C Kaul, Y Mitsui.   

Abstract

We have performed immunohistochemical studies of mortalin in normal and tumor human brain sections. In normal brain sections, the expression was seen mainly as being confined to neurons. Normal astrocytes showed undetectable expression of this unique member of the heat shock 70 protein family. Three grades of astrocyte tumors (low-grade astrocytoma, anaplastic astrocytoma, and glioblastoma), however, showed an increasing number of mortalin-positive cells. Other types of brain tumors, such as meningiomas, neurinomas, pituitary adenomas, and metastases, also showed elevated levels of mortalin expression compared to those in the normal brain. Mortalin has earlier been reported to have differential intracellular distribution in normal and transformed cells in vitro. Therefore, we substantiated the present study with immunofluorescence localization of the protein in normal and glioblastoma cells. The observations indicated that the tumors might be expressing a nonpancytosolic mortalin. An increase in number of mortalin-positive cells with malignant progression of brain tumors and its correlation with Ki-67 (a cell proliferation marker)-positive cells further suggested an involvement of nonpancytosolic mortalin(s) in malignant transformation of cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417864     DOI: 10.1006/excr.1997.3754

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  26 in total

1.  An N-terminal region of mot-2 binds to p53 in vitro.

Authors:  S C Kaul; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

2.  Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94.

Authors:  S Takano; R Wadhwa; Y Mitsui; S C Kaul
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 3.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

Review 4.  Emission of membrane vesicles: roles in complement resistance, immunity and cancer.

Authors:  David Pilzer; Olivier Gasser; Oren Moskovich; Jurg A Schifferli; Zvi Fishelson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

5.  Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.

Authors:  Lena F Burbulla; Carina Schelling; Hiroki Kato; Doron Rapaport; Dirk Woitalla; Carola Schiesling; Claudia Schulte; Manu Sharma; Thomas Illig; Peter Bauer; Stephan Jung; Alfred Nordheim; Ludger Schöls; Olaf Riess; Rejko Krüger
Journal:  Hum Mol Genet       Date:  2010-09-02       Impact factor: 6.150

Review 6.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 7.  Intracellular monovalent ions as second messengers.

Authors:  S N Orlov; P Hamet
Journal:  J Membr Biol       Date:  2006-08-14       Impact factor: 1.843

8.  Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.

Authors:  Travis J Cook; Jake G Hoekstra; David L Eaton; Jing Zhang
Journal:  Brain Pathol       Date:  2015-07-27       Impact factor: 6.508

9.  Kinetic and structural characterization of human mortalin.

Authors:  Wen-I Luo; Eric Dizin; Taejin Yoon; James A Cowan
Journal:  Protein Expr Purif       Date:  2010-02-10       Impact factor: 1.650

10.  Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.

Authors:  So Jung Park; Ji Hyun Shin; Jae In Jeong; Ji Hoon Song; Yoon Kyung Jo; Eun Sung Kim; Eunjoo H Lee; Jung Jin Hwang; Eun Kyung Lee; Sun Ju Chung; Jae-Young Koh; Dong-Gyu Jo; Dong-Hyung Cho
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.